Hospital officials said the acquisition is part of the hospital’s continued investment in the latest technology. Mountainside has offered robotic-assisted surgeries for a decade. The new Mako gives patients a minimally invasive option for total hip, total knee and partial knee replacements.
Mako SmartRobotics combines three key components — 3D CT-based planning, AccuStop haptic technology and insightful data analytics — into one platform that has improved outcomes for patients. The highly advanced robotic technology enables patients to recover faster and more effectively.
Mountainside Medical Center CEO Tim O’Brien said the acquisition will have impact on care.
Mountainside Medical Center has been serving Montclair and its surrounding New Jersey communities since 1891. The hospital provides patients immediate access to innovative and effective treatment alternatives at specialized centers within the hospital that focus on imaging, women’s health, cancer care, surgery, obesity, stroke and chronic kidney disease.
“Mountainside is proud to be able to offer this highly advanced robotic technology in our community,” he said. “The hospital is accredited by the Joint Commission in total joint — hip and total joint knee replacements. This addition to our orthopedic service line further demonstrates our commitment to provide the community with outstanding health care.”
Dr. Thomas John, an orthopedic surgeon, explained how.
“The Mako robot is changing the way surgeons are performing joint replacements,” he said. “Mako’s 3D CT allows surgeons to create a personalized plan based on each patient’s unique anatomy before entering the operating room. During surgery, the surgeon can validate that plan and make necessary adjustments while guiding the robotic arm to perform that plan.
“It’s exciting to be able to offer this transformative technology in a community hospital.”